You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: September 26, 2023

Purepac Pharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PUREPAC PHARM, and what generic and branded alternatives to PUREPAC PHARM drugs are available?

PUREPAC PHARM has one hundred and thirty approved drugs.

There are two tentative approvals on PUREPAC PHARM drugs.

Summary for Purepac Pharm

US Patents:	0
Tradenames:	62
Ingredients:	61
NDAs:	130

Drugs and US Patents for Purepac Pharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Purepac Pharm	CHLORDIAZEPOXIDE HYDROCHLORIDE	chlordiazepoxide hydrochloride	CAPSULE;ORAL	085155-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Purepac Pharm	RAUWOLFIA SERPENTINA	rauwolfia serpentina root	TABLET;ORAL	080842-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Purepac Pharm	ERYTHROMYCIN STEARATE	erythromycin stearate	TABLET;ORAL	061743-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Purepac Pharm	TETRACYCLINE HYDROCHLORIDE	tetracycline hydrochloride	SUSPENSION;ORAL	060291-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Purepac Pharm	CLORAZEPATE DIPOTASSIUM	clorazepate dipotassium	TABLET;ORAL	072330-001	Aug 8, 1988		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Medtronic

McKesson

Mallinckrodt

Harvard Business School

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.